Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2

By  

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 627-631

Karger

Access to resources Recommend Favorite

Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1

By  

Digestive Diseases, Vol. 33, Iss. 6, 2015-0 ,pp. : 708-714

Karger

Access to resources Recommend Favorite

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load

By Tsubota Akihito   Arase Yasuji   Suzuki Fumitaka   Suzuki Yoshiyuki   Akuta Norio   Hosaka Tetsuya   Someya Takashi   Kobayashi Masahiro   Saitoh Satoshi   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse

By Lagging Martin  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 7, 2013-07 ,pp. : 839-847

Informa Healthcare

Access to resources Recommend Favorite

Peginterferon α-2a Combination Therapies in Chronic Hepatitis C Patients Who Relapsed After or Had a Viral Breakthrough on Therapy with Standard Interferon α-2b Plus Ribavirin: A Pilot Study of Efficacy and Safety

By Herrine Steven   Brown Robert   Bernstein David   Ondovik Michael   Lentz Ellen   Te Helen  

Digestive Diseases and Sciences, Vol. 50, Iss. 4, 2005-04 ,pp. : 719-726

Springer Publishing Company

Access to resources Recommend Favorite